Sex Hormones and Lung Inflammation

Area of Science:

• Immunology
• Endocrinology
• Pulmonology

Background:

• Inflammation is central to lung diseases like asthma, COPD, pulmonary fibrosis, lung cancer, and infections.
• Immune cells (macrophages, lymphocytes) release cytokines, driving inflammatory processes.
• Reported gender differences exist in the incidence and severity of these lung conditions.

Purpose of the Study:

• To review recent findings on inflammatory cellular responses in major lung diseases.
• To examine the role of sex hormones (androgens, estrogens) in modulating lung inflammation.
• To discuss signaling pathways involved in sex steroid influence on lung disease development.

Main Methods:

• Literature review of current research on inflammation and sex hormones in lung diseases.
• Analysis of studies investigating cellular and molecular mechanisms.
• Synthesis of data on asthma, COPD, pulmonary fibrosis, lung cancer, and COVID-19.

Main Results:

• Androgens generally exhibit anti-inflammatory effects, e.g., in asthma by targeting ILC2s and Th2 cells.
• Estrogens may promote pro-inflammatory responses, including neutrophilic inflammation in asthma and COPD.
• Estrogen receptor activation is linked to potential tumorigenesis.

Conclusions:

• Sex hormones play a critical role in the pathogenesis and progression of various lung diseases.
• Understanding these sex-specific inflammatory patterns is crucial for developing targeted therapies.
• Further research into sex steroid signaling pathways can offer new therapeutic strategies for lung disorders.